Corrigendum to "Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation" [Clin Microbiol Infect 28 (12) (2022 Dec) 1657-1658]
1 Department of Molecular Medicine, Sapienza University of Rome, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
2 North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: daniele.focosi@gmail.com.
3 Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, Unit of Adverse Drug Reactions Monitoring, Pisa University Hospital, Pisa, Italy.
4 Scientific Department, Army Medical Center, Rome, Italy.
5 Department of Public Health and Infectious Diseases, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.